167 related articles for article (PubMed ID: 13048610)
1. A micro-method for the determination of paraaminosalicylic acid (aminosallyl) PAS and n-acetyl-para-aminosalicylic acid (acetyl-PAS).
NIELSEN E; PRAETORIUS E
Scand J Clin Lab Invest; 1952; 4(4):313-8. PubMed ID: 13048610
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of Para-Aminosalicylic Acid and Its 2 Major Metabolites: A Potential Relationship to the Development of Gastrointestinal Intolerance.
Adams KT; Donald PR; Abulfathi AA; Diacon AH; Stander MA; Reuter H
J Clin Pharmacol; 2020 Apr; 60(4):489-494. PubMed ID: 31682027
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic evaluation of para-aminosalicylic acid granules.
Peloquin CA; Henshaw TL; Huitt GA; Berning SE; Nitta AT; James GT
Pharmacotherapy; 1994; 14(1):40-6. PubMed ID: 8159600
[TBL] [Abstract][Full Text] [Related]
4. Para-aminosalicylic-acid (PAS) concentrations in the serum during treatment with various PAS preparations.
CITRON KM; KUPER SW
Tubercle; 1959 Dec; 40():443-52. PubMed ID: 13693755
[No Abstract] [Full Text] [Related]
5. Brain regional pharmacokinetics of p-aminosalicylic acid and its N-acetylated metabolite: effectiveness in chelating brain manganese.
Hong L; Jiang W; Pan H; Jiang Y; Zeng S; Zheng W
Drug Metab Dispos; 2011 Oct; 39(10):1904-9. PubMed ID: 21768272
[TBL] [Abstract][Full Text] [Related]
6. Determination of blood levels of para-aminosalicylic acid (PAS) in tuberculous patients treated with various PAS preparations.
BANG HO; STRANDGAARD E
Acta Tuberc Scand; 1957; 34(1-2):58-75. PubMed ID: 13508356
[No Abstract] [Full Text] [Related]
7. Determination of p-aminosalicylic acid and its N-acetylated metabolite in human urine by capillary zone electrophoresis as a measure of in vivo N-acetyltransferase 1 activity.
Cummins CL; O'Neil WM; Soo EC; Lloyd DK; Wainer IW
J Chromatogr B Biomed Sci Appl; 1997 Sep; 697(1-2):283-8. PubMed ID: 9342682
[TBL] [Abstract][Full Text] [Related]
8. [Clinical pharmacokinetics of para-aminosalicylic acid tablets].
Miroshnichenko II; Sokolova GB; Mokhireva LV
Antibiot Khimioter; 2009; 54(1-2):20-4. PubMed ID: 19499713
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of tuberculosis with p-aminosalicylic acid; experimental studies on PAS and sodium-PAS blood level after administration].
KOELZER PP; WEHR KH; GIESEN J
Arztl Forsch; 1953 Jul; 7(7):I/336-44. PubMed ID: 13091943
[No Abstract] [Full Text] [Related]
10. Plasma concentrations of para-aminosalicylic acid (PAS) after oral and rectal administration as influenced by p-(di-n-propylsulfamyl)-benzoic acid (benemid).
RIEBER CW; SALINE M; FRIEDMAN MM
Am Rev Tuberc; 1951 Oct; 64(4):448-52. PubMed ID: 14885675
[No Abstract] [Full Text] [Related]
11. Elimination of para-aminosalicylic acid in patients with liver disease and renal insufficiency.
Held H; Fried F
Chemotherapy; 1977; 23(6):405-15. PubMed ID: 923330
[TBL] [Abstract][Full Text] [Related]
12. Continued studies in concentrations of para-amino-salicylic acid (PAS) in the blood.
FROSTAD S
Acta Tuberc Pneumol Scand; 1961; 41():68-82. PubMed ID: 13895556
[No Abstract] [Full Text] [Related]
13. The concentration of PAS in the blood during medication with PAS or PAS-salts.
NILSSON H
Tubercle; 1953 Apr; 34(4):100-4. PubMed ID: 13049572
[No Abstract] [Full Text] [Related]
14. [PAS concentration in blood in therapeutic use of PAS and its salts].
NILSSON H
Sven Lakartidn; 1952 Apr; 49(16):1044-50. PubMed ID: 14958642
[No Abstract] [Full Text] [Related]
15. [Comparative concentration of PAS in blood following oral administration of PAS alone and with vitamin C].
NEDELJKOVIC J; DUGANDZIC S; DUGANDZIC M; TUCAKOVIC M
Vojnosanit Pregl; 1954; 11(9-10):372-6. PubMed ID: 13226731
[No Abstract] [Full Text] [Related]
16. [PAS blood content after peroral intake of different calcium-PAS-granulates].
SANZ MC; MULLER A
Schweiz Med Wochenschr; 1952 Dec; 82(52):1334-5. PubMed ID: 13028219
[No Abstract] [Full Text] [Related]
17. TWENTY YEARS AFTERWARD HISTORICAL NOTES ON THE DISCOVERY OF THE ANTITUBERCULOSIS EFFECT OF PARAAMINOSALICYLIC ACID (PAS) AND THE FIRST CLINICAL TRIALS.
LEHMANN J
Am Rev Respir Dis; 1964 Dec; 90():953-6. PubMed ID: 14233801
[No Abstract] [Full Text] [Related]
18. [THE EFFECTIVENESS OF TREATMENT WITH COMBINED ISONIAZID AND PARA-AMINOSALICYLIC ACID (PAS) AND WITH ISONIAZID AND PARA-AMINOBENZOIC ACID (PABA) IN EXPERIMENTAL TUBERCULOSIS IN GUINEA PIGS].
VITOLO A
Riv Patol Clin; 1963 Oct; 18():621-8. PubMed ID: 14112642
[No Abstract] [Full Text] [Related]
19. [Techniques of chromatography and determination of para-aminosalicylic acid and its derivatives in biological fluids].
GUILLAUME J; PETIT H
Ann Inst Pasteur Lille; 1958-1959; 10():73-88. PubMed ID: 13963408
[No Abstract] [Full Text] [Related]
20. [Oral administration of PAS].
RENARD J; COULET M; RIMBAULT Y
Therapie; 1952; 7(4):362-7. PubMed ID: 12984373
[No Abstract] [Full Text] [Related]
[Next] [New Search]
